181 related articles for article (PubMed ID: 22651256)
21. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation.
Yao-Borengasser A; Rasouli N; Varma V; Miles LM; Phanavanh B; Starks TN; Phan J; Spencer HJ; McGehee RE; Reue K; Kern PA
Diabetes; 2006 Oct; 55(10):2811-8. PubMed ID: 17003347
[TBL] [Abstract][Full Text] [Related]
22. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
23. Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training.
Ruschke K; Fishbein L; Dietrich A; Klöting N; Tönjes A; Oberbach A; Fasshauer M; Jenkner J; Schön MR; Stumvoll M; Blüher M; Mantzoros CS
Eur J Endocrinol; 2010 Mar; 162(3):515-23. PubMed ID: 19966034
[TBL] [Abstract][Full Text] [Related]
24. Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation.
Floyd ZE; Stephens JM
Obes Res; 2004 Jun; 12(6):921-8. PubMed ID: 15229330
[TBL] [Abstract][Full Text] [Related]
25. SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR.
Pourcet B; Pineda-Torra I; Derudas B; Staels B; Glineur C
J Biol Chem; 2010 Feb; 285(9):5983-92. PubMed ID: 19955185
[TBL] [Abstract][Full Text] [Related]
26. PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice.
Katafuchi T; Holland WL; Kollipara RK; Kittler R; Mangelsdorf DJ; Kliewer SA
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12102-12111. PubMed ID: 30420515
[TBL] [Abstract][Full Text] [Related]
27. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.
Sun Z; Feng D; Fang B; Mullican SE; You SH; Lim HW; Everett LJ; Nabel CS; Li Y; Selvakumaran V; Won KJ; Lazar MA
Mol Cell; 2013 Dec; 52(6):769-82. PubMed ID: 24268577
[TBL] [Abstract][Full Text] [Related]
28. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
[TBL] [Abstract][Full Text] [Related]
29. HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis.
Lai PH; Wang WL; Ko CY; Lee YC; Yang WM; Shen TW; Chang WC; Wang JM
Biochim Biophys Acta; 2008 Oct; 1783(10):1803-14. PubMed ID: 18619497
[TBL] [Abstract][Full Text] [Related]
30. HDAC3 inhibition prevents oxygen glucose deprivation/reoxygenation-induced transendothelial permeability by elevating PPARγ activity in vitro.
Zhao Q; Yu Z; Zhang F; Huang L; Xing C; Liu N; Xu Y; Wang X
J Neurochem; 2019 Apr; 149(2):298-310. PubMed ID: 30347434
[TBL] [Abstract][Full Text] [Related]
31. SUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells.
Lu Y; Zhou Q; Shi Y; Liu J; Zhong F; Hao X; Li C; Chen N; Wang W
PLoS One; 2013; 8(11):e79815. PubMed ID: 24260304
[TBL] [Abstract][Full Text] [Related]
32. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.
Di Gregorio GB; Yao-Borengasser A; Rasouli N; Varma V; Lu T; Miles LM; Ranganathan G; Peterson CA; McGehee RE; Kern PA
Diabetes; 2005 Aug; 54(8):2305-13. PubMed ID: 16046295
[TBL] [Abstract][Full Text] [Related]
33. Brown Adipose Tissue PPARγ Is Required for the Insulin-Sensitizing Action of Thiazolidinediones.
Shibata Y; Eguchi J; Wada J
Acta Med Okayama; 2023 Jun; 77(3):243-254. PubMed ID: 37357625
[TBL] [Abstract][Full Text] [Related]
34. NCoR negatively regulates adipogenic differentiation of mesenchymal stem cells.
Hong-Wei G; Lan L; De-Guo X; Zhong-Hao L; Peng R; Zhi-Qiang L; Guo-Qiang S; Ming-Zhi G
In Vitro Cell Dev Biol Anim; 2015 Aug; 51(7):749-58. PubMed ID: 26019118
[TBL] [Abstract][Full Text] [Related]
35. Contribution of HDAC3 to transcriptional repression by the human papillomavirus 31 E8^E2 protein.
Dreer M; Blondzik S; Straub E; Iftner T; Stubenrauch F
J Gen Virol; 2020 Jul; 101(7):751-759. PubMed ID: 32421493
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
[TBL] [Abstract][Full Text] [Related]
37. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
Sharma AM; Staels B
J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
[TBL] [Abstract][Full Text] [Related]
38. PPARγ activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats.
Sato D; Oda K; Kusunoki M; Nishina A; Takahashi K; Feng Z; Tsutsumi K; Nakamura T
Eur J Pharmacol; 2016 Feb; 773():71-7. PubMed ID: 26825545
[TBL] [Abstract][Full Text] [Related]
39. Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.
Mayi TH; Duhem C; Copin C; Bouhlel MA; Rigamonti E; Pattou F; Staels B; Chinetti-Gbaguidi G
FEBS J; 2010 Aug; 277(16):3308-20. PubMed ID: 20608974
[TBL] [Abstract][Full Text] [Related]
40. Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats.
Hsiao G; Chapman J; Ofrecio JM; Wilkes J; Resnik JL; Thapar D; Subramaniam S; Sears DD
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E164-74. PubMed ID: 20959535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]